Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Streamlining Phase I/II Oncology Trials: A Global CRO Partnership 3/17/2025

    Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.

  2. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

    Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

  3. Optimizing Time And Cost Efficiency In Cell Line Development 10/28/2024

    Discover a system that automates mAb purification, reducing time and costs in cell line development while improving reproducibility, with faster processing than traditional methods.

  4. Improve Speed To Market By Mitigating Vial And Stopper Incompatibility 10/1/2024

    These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.

  5. Success Story: Increased Productivity With Concentrated Fed-Batch 6/30/2025

    Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.

  6. Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers 9/30/2025

    Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.

  7. Direct Inoculation From Cryopreserved Cell Banks Using An Automated FBR 7/19/2024

    Directly inoculated your HEK293 cells into the bioreactor from cryopreservation vials or bags just using this fixed bed bioreactor (FBR) system's automated process steps.

  8. Expansion Of Human Umbilical Cord-Derived MSCs 7/18/2025

    Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.

  9. Perspectives On Performance, Scalability, And Regulatory Compliance 10/28/2024

    Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.

  10. Expert Insights In Navigating CGT's Complex Supply Chain 10/30/2024

    Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.